Previous studies have reported that the SPP1 + Macrophage-Fibroblast structure in hepatocellular carcinoma can inhibit the efficacy of PD-1 blockade therapy [28, 29]. This evidence concerns the gene SPP1 and hepatocellular carcinoma.